OPHTHAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ophthaine, and when can generic versions of Ophthaine launch?
Ophthaine is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in OPHTHAINE is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ophthaine
A generic version of OPHTHAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OPHTHAINE?
- What are the global sales for OPHTHAINE?
- What is Average Wholesale Price for OPHTHAINE?
Summary for OPHTHAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Patent Applications: | 4,053 |
| DailyMed Link: | OPHTHAINE at DailyMed |
US Patents and Regulatory Information for OPHTHAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | OPHTHAINE | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 008883-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
